September 2025

Introduction Scientific discovery is the engine of the biotech sector, but turning a promising molecule or device into a profitable therapy requires a strategic leap into commercialization. For innovators targeting the high-growth markets of Asia

IntroductionFor pharmaceutical and biotech innovators, securing regulatory approval often feels like navigating a labyrinth. In markets across Asia and the Middle East, this challenge is amplified by diverse local requirements, constantly evolving standards (DRAP, GCC),